Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000598795 | SCV000710402 | uncertain significance | not provided | 2020-10-12 | criteria provided, single submitter | clinical testing | Not observed in large population cohorts (Lek et al., 2016); In silico analysis supports a deleterious effect on protein structure/function; In-frame deletion in a repetitive region with no known function; Has not been previously published as pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: 31618753) |
Labcorp Genetics |
RCV002532694 | SCV002931618 | uncertain significance | Pierpont syndrome | 2024-08-13 | criteria provided, single submitter | clinical testing | This variant, c.333_350del, results in the deletion of 6 amino acid(s) of the TBL1XR1 protein (p.Ala113_Ala118del), but otherwise preserves the integrity of the reading frame. This variant is not present in population databases (gnomAD no frequency). This variant has been observed in individual(s) with TBLXR1-related conditions (PMID: 31618753). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 504096). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |